US › Healthcare

Alcon AG (ALC)

US · Healthcare · Medical Instruments & Supplies

$70.99+1.11%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$2.65B

Revenue YoY

+7.3%

Net profit

$185.3M

Profit YoY

-47.0%

EPS

$0.85

EPS estimate

$0.82

Net margin

7.0%

EPS came in at 0.85 against a street estimate of 0.82 — a beat of 3.7%.

Key statistics

Market cap

$34.24B

P/E

42.0

Forward P/E

20.0

P/B

1.52

Book value

$45.38

EPS (TTM)

$1.67

Dividend yield

0.52%

52-week high

$89.97

52-week low

$61.84

50-day MA

$67.28

200-day MA

$74.82

Beta

0.69

Analyst view

Analysts rate Alcon AG a buy (21 buy, 6 hold, 0 sell out of 27) with an average price target of $87.32.

Shareholding

Insiders

0.18%

Institutions

65.93%

Largest institutional holders

Fund	Stake
Bank of New York Mellon Corp	3.21%
Vanguard Capital Management, LLC	3.05%
FMR Inc	2.55%
Aristotle Capital Management LLC	1.99%
Ako Capital Llp	1.91%
Zurcher Kantonalbank	1.65%
UBS Group AG	1.22%
The Goldman Sachs Group Inc	1.19%

Corporate actions

Action	Detail	Date
Dividend	$0.36 / share ex-date May 6, 2026 · pay May 7, 2026	2026-05-06

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Alcon AG — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.